Advanced
Product
Solutions
Partners
Resources
Company
Toggle menu
Home
/
Photys Therapeutics
Photys Therapeutics
Overview
Locations
Financials
Operating Metrics
Human Capital
Key People
Competitors
Supplier Risk
Photys Therapeutics
Total Funding
$75 M
Photys Therapeutics Summary
Company Summary
Overview
Photys Therapeutics is a healthcare company developing phosphorylation-inducing chimeric small molecule medicines (PHICS). It focuses on protein modifications to treat diseases such as cancer, immune, metabolic, and rare diseases.
Type
Private
Status
Active
Founded
2021
HQ
Cambridge, MA, US
|
view all locations
Website
https://www.photys.com/
Cybersecurity rating
Sectors
Healthcare
medical diagnostics
oncology
platform
Homepage
Linkedin
Table of Contents
Key People
Locations
Competitors
Key People
Brian Fenton,
President and CEO
Linkedin
Edward Holson,
Chief Scientific Officer, Co-Founder
Linkedin
Jeff Capello,
Interim Chief Financial Officer
Lizzie Ngo,
Founding VP
Linkedin
and 1 others
Locations
View all
1 location detected
Cambridge, MA
HQ
United States
1 Broadway
Competitors and Similar Companies
Bio-Reference Laboratories
Healthcare - Subsidiary
Harbinger Health
Healthcare - Subsidiary
MyCartis
Healthcare - Private
Predicine
Healthcare - Private
Compare competitors
Footer menu
Contact us
Product
Intelligence Suite
Supplier Intelligence Platform
Craft Intelligence Portal
Craft API
Craft for Teams
Supplier Intelligence Platform
Craft Alerts
Craft N-Tier Mapping
Craft Risk Hub
Chrome extension
Solutions
Supplier Intelligence
Sales Intelligence
Aerospace and Defense
Resources
Resource center
Blog
Company
About
Careers
Contact
Terms of Service
Privacy Policy
Security
© Craft.co 2026
Share price data provided by IEX
Back
to top